Article
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.
International journal of antimicrobial agents - 1 Jan 2010
Livermore David M, Hill Robert L R, Thomson Hazel, Charlett André, Turton Jane F, Pike Rachel, Patel Bharat C, Manuel Rohini, Gillespie Stephen, Balakrishnan Indran, Barrett Stephen P, Cumberland Nigel, Twagira Mary
Abstract excerpt
Carbapenem- and multiply-resistant Acinetobacter baumannii (C-MRAB) are challenging pathogens, often susceptible only to polymyxins and tigecycline. We reviewed clinical outcomes in relation to antibiotic treatment for 166 consecutive patients infected or colonised with these organisms at 18 hospitals around London, UK. Clinical data were obtained along with the isolates, which were typed by pulsed-field gel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.